---
figid: PMC6835115__tlcr-08-05-667-f3
figlink: /pmc/articles/PMC6835115/figure/f3/
number: Figure 3
caption: Our model. PAK1 activates the PI3K/AKT signaling pathway and PKCι activates
  PAK1 through Ect2 and RAC1. Auranofin with IPA-3 (liposomal formulation), or other
  PAK inhibitors, could become a therapeutic solution for EGFR-mutation positive NSCLC
  patients resistant to EGFR TKIs.
pmcid: PMC6835115
papertitle: Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer.
reftext: Masaoki Ito, et al. Transl Lung Cancer Res. 2019 Oct;8(5):667-673.
pmc_ranked_result_index: '19430'
pathway_score: 0.9343274
filename: tlcr-08-05-667-f3.jpg
figtitle: Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer
year: '2019'
organisms: Homo sapiens
ndex: 272eea65-de99-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6835115__tlcr-08-05-667-f3.html
  '@type': Dataset
  description: Our model. PAK1 activates the PI3K/AKT signaling pathway and PKCι activates
    PAK1 through Ect2 and RAC1. Auranofin with IPA-3 (liposomal formulation), or other
    PAK inhibitors, could become a therapeutic solution for EGFR-mutation positive
    NSCLC patients resistant to EGFR TKIs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - AKT2
  - AXL
  - CDCP1
  - ECT2
  - EGFR
  - MAPK1
  - MAPK3
  - JAK2
  - MAP2K1
  - MAP2K2
  - MET
  - PAK1
  - PRKCI
  - RAC1
  - HRAS
  - KRAS
  - NRAS
  - SRC
  - STAT3
  - YAP1
  - IPA
  - auranofin
  - Cancer
  - Lung cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AXL
  symbol: AXL
  source: hgnc_symbol
  hgnc_symbol: AXL
  entrez: '558'
- word: CDCP1
  symbol: CDCP1
  source: hgnc_symbol
  hgnc_symbol: CDCP1
  entrez: '64866'
- word: Ect2
  symbol: ECT2
  source: hgnc_symbol
  hgnc_symbol: ECT2
  entrez: '1894'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PKCI
  symbol: PKCI
  source: hgnc_alias_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (Src)
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: YAP1
  symbol: YAP1
  source: hgnc_symbol
  hgnc_symbol: YAP1
  entrez: '10413'
chemicals:
- word: IPA
  source: MESH
  identifier: C507406
- word: auranofin
  source: MESH
  identifier: D001310
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
